StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.88−0.08 (-4.08%)

Close on Nov 19, 2026Market cap $177.76MP/E 4.9Yield –

Compugen gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $63.51M, up 218.6% from the year before. Over ten years it grew 50.9% a year on average. The highest annual figure on record is $63.51M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$63.51M+218.6%
FY2024Dec 31, 2024$19.93M-36.6%
FY2023Dec 31, 2023$31.46M+382.1%
FY2022Dec 31, 2022$6.53M+22.7%
FY2021Dec 31, 2021$5.32M+174.2%
FY2020Dec 31, 2020$1.94M-88.4%
FY2018Dec 31, 2018$16.77M+3328.6%
FY2016Dec 31, 2016$489.00K-93.6%
FY2015Dec 31, 2015$7.64M-15.3%
FY2014Dec 31, 2014$9.02M+767.6%
FY2013Dec 31, 2013$1.04M+2436.6%
FY2012Dec 31, 2012$41.00K-95.4%
FY2010Dec 31, 2010$891.00K+256.4%
FY2009Dec 31, 2009$250.00K–

More Compugen figures

See a number that looks wrong?